| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales,
operating profit, depreciation and amortization, interest expense,
income tax (expense) benefit, other comprehensive loss, and assets
for the years ended November 30, 2018 and 2017:
|
|
|
|
|
|
|
|
|
| |
|
For the years ended November 30, |
|
| |
|
2018 |
|
|
2017 |
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
28,817,872 |
|
|
$ |
24,942,089 |
|
|
PrepaCyte CB
|
|
|
104,323 |
|
|
|
442,190 |
|
|
Public cord blood banking
|
|
|
296,295 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total net revenue
|
|
$ |
29,218,490 |
|
|
$ |
25,384,279 |
|
|
|
|
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
7,744,208 |
|
|
$ |
6,257,628 |
|
|
PrepaCyte CB
|
|
|
169,397 |
|
|
|
466,763 |
|
|
Public cord blood banking
|
|
|
626,057 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total cost of sales
|
|
$ |
8,539,662 |
|
|
$ |
6,724,391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
5,620,394 |
|
|
$ |
5,067,228 |
|
|
PrepaCyte CB
|
|
|
(101,329 |
) |
|
|
(61,002 |
) |
|
Public cord blood banking
|
|
|
(329,762 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total operating profit
|
|
$ |
5,189,303 |
|
|
$ |
5,006,226 |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
281,072 |
|
|
$ |
193,741 |
|
|
PrepaCyte CB
|
|
|
36,254 |
|
|
|
36,254 |
|
|
Public cord blood banking
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization
|
|
$ |
317,326 |
|
|
$ |
229,995 |
|
|
|
|
|
|
|
|
|
|
|
Interest expense:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
1,546,900 |
|
|
$ |
1,302,650 |
|
|
PrepaCyte CB
|
|
|
— |
|
|
|
— |
|
|
Public cord blood banking
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
$ |
1,546,900 |
|
|
$ |
1,302,650 |
|
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
(4,472,504 |
) |
|
$ |
(1,308,603 |
) |
|
PrepaCyte CB
|
|
|
— |
|
|
|
— |
|
|
Public cord blood banking
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total income tax (expense) benefit
|
|
$ |
(4,472,504 |
) |
|
$ |
(1,308,603 |
) |
|
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
300,119 |
|
|
$ |
6,457 |
|
|
PrepaCyte CB
|
|
|
— |
|
|
|
— |
|
|
Public cord blood banking
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
$ |
300,119 |
|
|
$ |
6,457 |
|
|
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of
November 30 2018 and November 30, 2017:
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
26,239,260 |
|
|
$ |
23,360,714 |
|
|
PrepaCyte CB
|
|
|
319,802 |
|
|
|
549,283 |
|
|
Public cord blood banking
|
|
|
15,831,081 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
42,390,143 |
|
|
$ |
23,909,997 |
|
|
|
|
|
|
|
|
|
|
|